Source: Pharmabiz

Foundation Medicine: Foundation Medicine teams up with Sumitomo Pharma America to advance treatment for patients with acute leukaemia with NPM1 mutations using FoundationOne Heme platform

Foundation Medicine, Inc, a genomics company committed to transforming cancer care, announced a collaboration with Sumitomo Pharma America, Inc. (SMPA) to develop the FoundationOne Heme

Read full article »
Foundation Medicine's Competitors | Foundation Medicine's News | Foundation Medicine's Financials
Stay up-to-date with the latest news on Foundation Medicine
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Dan Malarek's photo - CEO of Foundation Medicine

CEO

Dan Malarek

CEO Approval Rating

82/100

Read more
Stay up-to-date with the latest news on Foundation Medicine